Page results
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
This is information for women who have been given a diagnosis of adenomyosis.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Bones marrow harvest patient information page.
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
File results
-
FOI2017223 Patients not eligible for NHS care
-
FOI2017219 Haemophilia patients treated
-
FOI2017218 Patients diagnosed as being on the foetal alcohol spectrum
-
FOI2017214 Details of the heads of estates and capital project managers
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023
-
FOI2017204 Children treated for alcohol or drug related issues
-
FOI2017195 Patients attending A&E in mental crisis or after self-harming
-
FOI2017200 Falls prevention and rheumatology patients
-
FOI2017225 Data capture in operating theatres
-
FOI2017207 Patients referred for IVF treatment